Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Pricing Pressure Accelerates Adoption At $149/month self-pay for the starter dose, oral GLP-1s enter the market at a materially more accessible price point than injectable WEGOVY (which retails at $1,349/month before discounts)
Providers can sign up for early access here: BPC-157 Recommended for 503A Bulks List The Committee just voted to recommend BPC-157, both free base and acetate, for inclusion on the 503A Bulks List
The brand also emphasizes the ongoing support component - the Omzo app, care team access, and clinician follow-up - as differentiating features
Versus other regeneratives: Versus BPC-157 (15 AA, dose 500 mcg-1 mg): BPC-157 is mostly oriented towards gastro-protection, tendon and vascular regeneration (angiogenesis via VEGF, nitric oxide pathway)
.jpg)
